Xiaoli Ma

1.4k total citations
112 papers, 878 citations indexed

About

Xiaoli Ma is a scholar working on Neurology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoli Ma has authored 112 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Neurology, 34 papers in Molecular Biology and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoli Ma's work include Neuroblastoma Research and Treatments (40 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Sarcoma Diagnosis and Treatment (11 papers). Xiaoli Ma is often cited by papers focused on Neuroblastoma Research and Treatments (40 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Sarcoma Diagnosis and Treatment (11 papers). Xiaoli Ma collaborates with scholars based in China, United States and Canada. Xiaoli Ma's co-authors include Wen Zhao, Zhixia Yue, Mei Jin, Chao Duan, Pengfei Tu, Yan Su, Qian Yu, Yong Jiang, Huanmin Wang and Xuemei Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Xiaoli Ma

105 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Ma China 16 314 237 209 171 129 112 878
Qingyun Tian United States 17 447 1.4× 319 1.3× 89 0.4× 108 0.6× 68 0.5× 23 1.1k
Libo Zhang Canada 20 533 1.7× 317 1.3× 384 1.8× 332 1.9× 216 1.7× 47 1.2k
Mario Damiano Toro Italy 27 388 1.2× 189 0.8× 110 0.5× 138 0.8× 63 0.5× 148 2.1k
Hongyang Zhao China 16 376 1.2× 203 0.9× 117 0.6× 286 1.7× 62 0.5× 54 877
Tao Xu China 21 527 1.7× 91 0.4× 208 1.0× 317 1.9× 184 1.4× 84 1.3k
Aijun Zhang China 16 233 0.7× 154 0.6× 164 0.8× 92 0.5× 101 0.8× 57 907
Yanhui Liu China 16 298 0.9× 114 0.5× 88 0.4× 221 1.3× 141 1.1× 101 884
Ryuichi Saura Japan 15 431 1.4× 152 0.6× 115 0.6× 207 1.2× 32 0.2× 52 1.2k
Jue Wang China 17 224 0.7× 87 0.4× 184 0.9× 128 0.7× 267 2.1× 105 868
Ran Cheng China 16 394 1.3× 64 0.3× 129 0.6× 235 1.4× 115 0.9× 54 1.3k

Countries citing papers authored by Xiaoli Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Ma more than expected).

Fields of papers citing papers by Xiaoli Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Ma. The network helps show where Xiaoli Ma may publish in the future.

Co-authorship network of co-authors of Xiaoli Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Ma. A scholar is included among the top collaborators of Xiaoli Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Ma. Xiaoli Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zheng, Lu, Junying Zhou, Youxin Ji, et al.. (2024). 54P BL-B01D1, an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic biliary tract carcinoma (BTC). Annals of Oncology. 35. S233–S233. 2 indexed citations
3.
Liu, Xiulan, Yanyan Xu, Brant G. Wang, et al.. (2023). Bronchiolar adenoma/ciliated muconodular papillary tumour: advancing clinical, pathological, and imaging insights for future perspectives. Clinical Radiology. 79(2). 85–93. 1 indexed citations
4.
Xu, Na, et al.. (2023). Particle implantation combined with chemotherapy for rhabdomyosarcoma of the head and neck: A 8‐year long‐term follow‐up case report. SHILAP Revista de lepidopterología. 2(3). 233–236. 1 indexed citations
5.
Cheng, Qing, Xiaoli Ma, Jingjing Liu, et al.. (2023). Pharmacological Inhibition of the Asparaginyl Endopeptidase (AEP) in an Alzheimer’s Disease Model Improves the Survival and Efficacy of Transplanted Neural Stem Cells. International Journal of Molecular Sciences. 24(9). 7739–7739. 9 indexed citations
6.
Li, Miao, Mei Jin, Wen Zhao, et al.. (2023). Clinical characteristics of malignant germ cell tumors in adolescents: A multicenter 10‐year retrospective study in Beijing. SHILAP Revista de lepidopterología. 2(6). 524–531. 1 indexed citations
7.
Wang, Ting, Fanfan Li, Xiaolan Wang, et al.. (2023). Evaluation of Recovery Efficacy of Inspiratory Muscle Training After Lobectomy Based on Computed Tomography 3D Reconstruction. Respiratory Care. 69(1). 42–49. 1 indexed citations
8.
Wang, Shengcai, Ping Chu, Yaqiong Jin, et al.. (2022). Clinical and surgical outcome differences on the basis of pathology category in cervical neuroblastic tumors. Journal of Pediatric Surgery. 57(12). 926–933.
9.
Song, Qiaoling, Yuchao Zhang, Minghui Zhang, et al.. (2022). Identifying gene variants underlying the pathogenesis of diabetic retinopathy based on integrated genomic and transcriptomic analysis of clinical extreme phenotypes. Frontiers in Genetics. 13. 929049–929049. 2 indexed citations
10.
Su, Yan, et al.. (2021). Case Report : Li-Fraumeni Syndrome with Central Nervous System Tumors in Two Siblings. BMC Pediatrics. 21(1). 588–588. 6 indexed citations
11.
Wang, Huanmin, Xiaoli Ma, Yongli Guo, et al.. (2020). Clinical Features of Children with Retinoblastoma and Neuroblastoma. Journal of Ophthalmology. 2020. 1–8. 7 indexed citations
12.
Chen, Xu, et al.. (2016). An improved simulation model for three-wire gas metal arc welding. The International Journal of Advanced Manufacturing Technology. 90(5-8). 1447–1456. 3 indexed citations
14.
Wang, Kai‐Ling, Lei Cui, Chao Gao, et al.. (2014). [Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia].. PubMed. 22(2). 285–90. 1 indexed citations
15.
Ma, Xiaoli, Jie Zheng, Mei Jin, et al.. (2014). Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in Chinese ALL children and possible association with mercaptopurine related toxicity.. PubMed. 7(7). 4552–6. 9 indexed citations
16.
Ma, Xiaoli, Mei Jin, Dawei Zhang, et al.. (2013). Clinical features and efficacy of recent treatment analysis of multimodality treatment for 91 children with neuroblastoma. Zhonghua shiyong erke linchuang zazhi. 28(3). 178–182. 3 indexed citations
17.
Ma, Xiaoli. (2012). Posterior Mediastinal Neuroblastoma in 35 Children. Testowy IndexCopernicus.
18.
Shahrbanian, Shahnaz, et al.. (2012). Use of virtual reality (immersive vs. non immersive) for pain management in children and adults: A systematic review of evidence from randomized controlled trials. European Journal of Experimental Biology. 2(5). 52 indexed citations
19.
Piao, Yue-Shan, et al.. (2011). IgG4-related idiopathic hypertrophic pachymeningitis: one case report and review of the literature. 11(5). 529–533. 2 indexed citations
20.
Wang, Yunshan, et al.. (2005). Development of an Oligochip for Genotyping Human Leukocyte Antigen-B51 and Its Clinical Application. Genetic Testing. 9(4). 292–296. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026